NAPSA Antikörper (AA 64-420)
-
- Target Alle NAPSA Antikörper anzeigen
- NAPSA (Napsin A Aspartic Peptidase (NAPSA))
-
Bindungsspezifität
- AA 64-420
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser NAPSA Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human, Maus
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Napsin-A protein (64-420AA)
- Isotyp
- IgG
- Top Product
- Discover our top product NAPSA Primärantikörper
-
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 20-158) antibody
NAPSA Reaktivität: Human, Ratte WB, ELISA, IHC Wirt: Maus Monoclonal 10C4B8 unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human WB, IHC, IF, FACS, StM Wirt: Maus Monoclonal NAPSA-1238 unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 25-250) antibodyNAPSA Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) antibodyNAPSA Reaktivität: Human, Maus WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human IHC, StM Wirt: Maus Monoclonal NAPSA-3309 unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human IHC Wirt: Kaninchen Monoclonal MSVA-112R unconjugated Recombinant Antibody
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 368-397), (C-Term) antibodyNAPSA Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal RB33879 unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human WB, IHC, IF, FACS, StM Wirt: Maus Monoclonal NAPSA-1238-NAPSA-1239 unconjugated
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human IHC, StM Wirt: Kaninchen Monoclonal NAPSA-1865R unconjugated Recombinant Antibody
anti-Napsin A Aspartic Peptidase (NAPSA) (AA 189-299) antibodyNAPSA Reaktivität: Human IHC, StM Wirt: Maus Monoclonal rNAPSA-1239 unconjugated Recombinant Antibody
-
- Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- NAPSA (Napsin A Aspartic Peptidase (NAPSA))
- Andere Bezeichnung
- NAPSA (NAPSA Produkte)
- Synonyme
- KAP antikoerper, Kdap antikoerper, NAP1 antikoerper, NAPA antikoerper, SNAPA antikoerper, pronapsin antikoerper, kap antikoerper, kdap antikoerper, nap1 antikoerper, napa antikoerper, napsa antikoerper, snapa antikoerper, napsin A aspartic peptidase antikoerper, napsin A aspartic peptidase L homeolog antikoerper, NAPSA antikoerper, Napsa antikoerper, napsa.L antikoerper
- Hintergrund
-
Background: May be involved in processing of pneumocyte surfactant precursors.
Aliases: Asp 4 antibody, ASP4 antibody, Aspartyl protease 4 antibody, KAP antibody, Kdap antibody, Kidney derived aspartic protease like protein antibody, NAP1 antibody, NAPA antibody, Napsa antibody, NAPSA_HUMAN antibody, Napsin 1 antibody, napsin A aspartic peptidase antibody, Napsin A precursor antibody, Napsin-1 antibody, Napsin-A antibody, Pronapsin A antibody, SNAPA antibody, TA01/TA02 antibody
- UniProt
- O96009
- Pathways
- Tube Formation, Asymmetric Protein Localization, Embryonic Body Morphogenesis
-
